BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16978223)

  • 1. Clinical implications of SOCS1 methylation in myelodysplastic syndrome.
    Wu SJ; Yao M; Chou WC; Tang JL; Chen CY; Ko BS; Huang SY; Tsay W; Chen YC; Shen MC; Wang CH; Yeh YC; Tien HF
    Br J Haematol; 2006 Nov; 135(3):317-23. PubMed ID: 16978223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients.
    Chaubey R; Sazawal S; Mahapatra M; Chhikara S; Saxena R
    Int J Lab Hematol; 2015 Apr; 37(2):265-71. PubMed ID: 25123164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic Value of Multigene Methylation in Patients with Myelodysplastic Syndrome].
    Deng CY; Chen S; Jiang M; Nilupar T; Wang H; Hao JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1118-1122. PubMed ID: 28823279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical Value of p15, DAPK, SOCS1 and FHIT Genes Combined Detection in the Early Diagnosis and Prognosis Evaluation of Myelodysplastic Syndrome].
    Deng CY; Chen S; Jiang M; Chen R; Nilupar T; Wang H; Hao JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1751-1755. PubMed ID: 29262910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
    Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U
    Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome.
    Chen CY; Lin LI; Tang JL; Ko BS; Tsay W; Chou WC; Yao M; Wu SJ; Tseng MH; Tien HF
    Br J Haematol; 2007 Nov; 139(3):405-14. PubMed ID: 17910630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
    Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
    Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
    Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
    Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
    Yang Y; Zhang Q; Xu F; Chang C; Li X
    Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome.
    Misawa S; Horiike S; Kaneko H; Kashima K
    Leukemia; 1997 Apr; 11 Suppl 3():533-5. PubMed ID: 9209448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative comparison of CDKN2B methylation in pediatric and adult myelodysplastic syndromes.
    Kim M; Kook H; Park HJ; Ahn HS; Lee KC; Lee KS; Park SK; Lim JY; Kim HK; Han DK; Lee DS;
    Acta Haematol; 2013; 130(2):115-21. PubMed ID: 23571652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant hypermethylation of CTNNA1 gene is associated with higher IPSS risk in patients with myelodysplastic syndrome.
    Qian J; Chen XX; Qian W; Yang J; Wen XM; Ma JC; Deng ZQ; Qian Z; Zhang YY; Lin J
    Clin Chem Lab Med; 2014 Dec; 52(12):1859-65. PubMed ID: 25153418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia.
    Hasegawa D; Manabe A; Kubota T; Kawasaki H; Hirose I; Ohtsuka Y; Tsuruta T; Ebihara Y; Goto Y; Zhao XY; Sakashita K; Koike K; Isomura M; Kojima S; Hoshika A; Tsuji K; Nakahata T
    Br J Haematol; 2005 Mar; 128(6):805-12. PubMed ID: 15755284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
    Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
    Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.
    Hou HA; Kuo YY; Tang JL; Chou WC; Yao M; Lai YJ; Lin CC; Chen CY; Liu CY; Tseng MH; Huang CF; Chiang YC; Lee FY; Liu MC; Liu CW; Huang SY; Ko BS; Wu SJ; Tsay W; Chen YC; Tien HF
    Am J Hematol; 2014 Feb; 89(2):181-6. PubMed ID: 24127063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
    Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
    Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan.
    Tien HF; Wang CH; Chuang SM; Chow JM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH
    Cancer Genet Cytogenet; 1994 May; 74(1):40-9. PubMed ID: 8194046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of SHP-1 promoter methylation in myelodysplastic syndromes and its related mechanism].
    Zhang YZ; Zhao DD; Zhao WP; Zhao HF; Zhao ZG; Wang YF; Wu XX; Han XP; Da WM
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):108-12. PubMed ID: 22730659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of hypermethylation of SOCS gene in typical myeloproliferative disease].
    Qin W; Li LL; Lu HN; Huang BB; Xiu B; Bo LJ; Gao QM; Zhang WJ; Fu JF
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):772-6. PubMed ID: 22339915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.